Cargando…
Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
BACKGROUND: Over the past decades, multiple approaches to aspiration sclerotherapy of large symptomatic hepatic cysts have been investigated. However, comparative data are scarce. OBJECTIVE: The objective of this article is to compare cyst reduction, symptomatic relief, and adverse events between et...
Autores principales: | Wijnands, Titus FM, Schoenemeier, Bastian, Potthoff, Andrej, Gevers, Tom JG, Groenewoud, Hans, Gebel, Michael J, Rifai, Kinan, Manns, Michael P, Drenth, Joost PH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047294/ https://www.ncbi.nlm.nih.gov/pubmed/30023070 http://dx.doi.org/10.1177/2050640618764940 |
Ejemplares similares
-
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015) -
Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021) -
Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations
por: Fukuzawa, Satoshi, et al.
Publicado: (2021) -
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018) -
Familial Disseminated Cutaneous Glomuvenous Malformation: Treatment with Polidocanol Sclerotherapy
por: Jha, Aditi, et al.
Publicado: (2016)